| Related Articles |
Prise en charge du cancer du col de l’utérus métastatique et/ou en rechute.
Bull Cancer. 2017 May;104 Suppl 1:S39-S42
Authors: Kurtz JE, D'Hondt V, Lécuru F, Lhommé C
Abstract
METASTATIC OR RECURRENT CERVICAL CANCER/TREATMENT: The prognosis of metastatic or recurrent cervical cancer remains dismal. The poor chemosensitivity of this tumor- is an issue, especially in case of recurrence in irradiated fields. Still, chemotherapy has shown some efficacy, and mostly consists in platinum-based doublets. The addition of bevacizumab to chemotherapy has been recently validated. However, most of these patients present with complex clinical situations and the treatment strategy has to be discussed in multidisciplinary tumor boards.
PMID: 28625314 [PubMed - in process]
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2sRov8V
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.